RE: Move up17 Nov 2020 13:53
Extract from the RNS @ Nolupus
In addition, Avion has asked the FDA to consider a conditional approval while the new Phase 3 is underway. A conditional approval, which would allow the marketing of Lupuzorβ’ prior to the completion of the new Phase 3, would be based on the clinically significant data previously generated in the completed Phase 2 and 3 clinical trials to date.
A nice 163k buy just filled